Table 4.
Outcome: MFQ total (T2) | |||
---|---|---|---|
B (95% CI) | Beta (standardised) | p value | |
Model 1: DMDD (T1): unadjusted | 6.52 (2.50, 10.53) | 0.21 | 0.002 |
Model 2: DMDD (T1): controlling for baseline age, gender, depression symptoms | 4.53 (0.53, 8.52) | 0.15 | 0.027 |
Model 3: DMDD (T1): controlling for baseline age, gender, depression symptoms, ADHD medication | 4.52 (0.51, 8.53) | 0.15 | 0.027 |
Model 4: DMDD (T1): controlling for baseline age, gender, depression symptoms and anxiety | 3.97 (− 0.019, 7.96) | 0.13 | 0.051 |
Model 5: DMDD (T1): controlling for baseline age, gender, depression symptoms and ADHD symptoms | 3.81 (− 0.25, 7.87) | 0.12 | 0.066 |
Model 6: DMDD (T1): controlling for baseline age, gender, depression symptoms, ADHD medication, anxiety and ADHD symptoms | 3.32 (− 0.74, 7.38) | 0.11 | 0.108 |
N for analysis = 224
MFQ Mood and Feelings Questionnaire, DMDD disruptive mood dysregulation disorder, ADHD attention-deficit/hyperactivity disorder, T1 at time 1, T2 at time 2, B unstandardised B coefficient (B is the difference in MFQ score at follow-up in those with DMDD compared to those without DMDD), Beta standardised beta coefficient (Beta is the standard deviation unit difference in MFQ score between those with DMDD and those without DMDD)